PBH
NYSE · Pharmaceuticals
Prestige Consumer Healthcare
$61.13
-0.87 (-1.40%)
Performance
1D
—
1W
—
1M
—
3M
-2.71%
6M
-1.32%
1Y
-28.08%
YTD
-0.15%
Open$62.75
Previous Close$62.00
Day High$63.02
Day Low$60.45
52W High$89.37
52W Low$57.25
Volume—
Avg Volume372.3K
Market Cap2.84B
P/E Ratio15.24
EPS$3.78
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$64.04
Below
SMA 200
$69.15
Below
RSI (14)
68.6
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
10 analysts
Price Target
+27.8% upside
Current
$61.13
$61.13
Target
$78.15
$78.15
$50.25
$78.15 avg
$108.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.06B | 1.04B | 462.83M |
| Net Income | 199.68M | 176.98M | 138.88M |
| Profit Margin | 18.9% | 17.9% | 30.0% |
| EBITDA | 328.55M | 307.39M | 217.92M |
| Free Cash Flow | — | — | 109.94M |
| Rev Growth | +1.5% | +1.5% | +15.0% |
| Debt/Equity | 0.55 | 0.55 | 0.82 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |